John B. Henneman III, EVP, Chief Financial Officer at NEWLINK GENETICS CORP ((NLNK)), sold 175 shares at $35.74 ($6K) on 2016-01-05, disclosed to the SEC on 2016-01-06.
Open-market sale of $6k (NLNK) by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| APRE | BUY | 2024-03-14 | $100K | — | Filing → |
| RCM | SELL | 2023-08-09 | $1.7M | — | Filing → |
| ANIK | BUY | 2021-05-20 | $86K | — | Filing → |